New drug could get bypass patients home days earlier
NCT ID NCT07357675
First seen Jan 23, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tests a new therapy called EA-230 to see if it helps people recover faster after coronary artery bypass surgery. In an earlier study, those who got EA-230 spent less time in the ICU and hospital and had fewer serious problems. This Phase 3 trial will involve 300 adults having bypass surgery to confirm if EA-230 is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MAYO clinic
Rochester, Minnesota, 55905, United States
-
Medisch Spectrum Twente
Enschede, Netherlands
-
RadboudUMC
Nijmegen, Netherlands
-
St Thomas' Hospital
London, United Kingdom
-
UZ Gent
Ghent, Belgium
Conditions
Explore the condition pages connected to this study.